(Q41201708)

28 September 2017

title

Dose dependent in vivo inhibition of human colorectal cancer (LoVo) by the gastrin receptor antagonist, CI-988. (English)

1 reference

28 September 2017

1 reference

Romani R

1

1 reference

28 September 2017

Howes LG

series ordinal

2

1 reference

28 September 2017

Morris DL

series ordinal

3

1 reference

28 September 2017

publication date

1 May 1996

1 reference

Clinical and Experimental Pharmacology and Physiology

28 September 2017

published in

1 reference

28 September 2017

volume

23

1 reference

28 September 2017

issue

5

1 reference

28 September 2017

page(s)

438-440

1 reference

Evidence for autocrine growth stimulation of cultured colon tumor cells by a gastrin/cholecystokinin-like peptide

28 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.1996.TB02756.X

Inhibition of cell proliferation by the cholecystokinin antagonist L-364,718.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.1996.TB02756.X

Inhibitory effects of the gastrin receptor antagonist (L-365,260) on gastrointestinal tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.1996.TB02756.X

Development of a class of selective cholecystokinin type B receptor antagonists having potent anxiolytic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.1996.TB02756.X

10.1111/J.1440-1681.1996.TB02756.X

21 January 2018

Identifiers

DOI

1 reference

28 September 2017

1 reference